HLA Typing Market by Technology (PCR (SSO, SSP, Real-time), Sequencing (NGS, Sanger's)), Product (Instruments, Reagents, Software), Application (Donor-recipient Cross-matching, Transfusion, Cancer), End User (Hospitals, Reference Labs) Global Forecasts to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered and Regional Scope
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders
1.6 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Indicative List of Secondary Sources
2.1.1.2 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Data from Primary Sources
2.1.2.3 Key Industry Insights
2.1.2.4 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.2.1 Revenue Mapping-based Market Estimation
2.2.2 End-user-based Mapping Market Estimation
2.3 Growth Forecasting Model
2.4 Data Triangulation and Market Breakdown
2.5 Research Assumptions
2.6 Research Limitations
2.7 Risk Analysis

4.1 Hla Typing Market Overview
4.2 Regional Snapshot of Hla Typing Market

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Number of Organ Transplantation Procedures
5.2.1.2 Increasing Technological Advancements in Sanger Sequencing
5.2.1.3 Growing Funding and Research Activities
5.2.1.4 Increasing Prevalence of Infectious and Autoimmune Diseases
5.2.2 Restraints
5.2.2.1 High Cost of Hla Typing Products
5.2.2.2 Limited Reimbursement Policies
5.2.3 Opportunities
5.2.3.1 Adoption of Cross-Matching and Chimerism Testing
5.2.3.2 Growth Opportunities in Emerging Markets
5.2.4 Challenges
5.2.4.1 Shortage of Skilled Professionals
5.2.4.2 Lack of Standardization Across Laboratories
5.3 Trends/Disruptions Impacting Customer Business
5.4 Pricing Analysis
5.4.1 Average Selling Price, by Instruments
5.4.2 Average Selling Price, by Reagents
5.4.3 Average Selling Price of Key Players, by Instruments
5.4.4 Average Selling Price Trend, by Region
5.5 Value Chain Analysis
5.5.1 R&D
5.5.2 Raw Material Procurement & Product Development
5.5.3 Marketing, Sales, and Distribution
5.5.4 Post-Sales Services
5.6 Supply Chain Analysis
5.6.1 Prominent Companies
5.6.2 Small and Medium-Sized Enterprises
5.6.3 End-users
5.7 Ecosystem Analysis
5.8 Investment and Funding Scenario
5.9 Technology Analysis
5.9.1 Key Technologies
5.9.1.1 Sequence-based Typing
5.9.1.2 Next-Generation Sequencing
5.9.2 Complementary Technologies
5.9.2.1 Sample Preparation & DNA Extraction Technologies
5.9.2.2 Bioinformatics and Data Analysis Software
5.9.3 Adjacent Technologies
5.9.3.1 Transplant Diagnostics
5.10 Patent Analysis
5.11 Trade Analysis
5.11.1 Import Scenario (HS Code 3822)
5.11.2 Export Scenario (HS Code 3822)
5.12 Key Conferences and Events, 2025-2026
5.13 Case Study Analysis
5.14 Regulatory Landscape
5.14.1 Regulatory Guidelines
5.14.1.1 North America
5.14.1.1.1 US
5.14.1.1.2 Canada
5.14.1.2 Europe
5.14.1.2.1 UK
5.14.1.2.2 France
5.14.1.2.3 Germany
5.14.1.3 Asia-Pacific
5.14.1.3.1 China
5.14.1.3.2 Japan
5.14.1.3.3 India
5.14.1.4 Latin America
5.14.1.4.1 Brazil
5.14.1.4.2 Mexico
5.14.1.5 Middle East & Africa
5.14.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.15 Porter's Five Force Analysis
5.15.1 Bargaining Power of Suppliers
5.15.2 Bargaining Power of Buyers
5.15.3 Threat of New Entrants
5.15.4 Threat of Substitutes
5.15.5 Intensity of Competitive Rivalry
5.16 Key Stakeholders and Buying Criteria
5.16.1 Key Stakeholders in Buying Process
5.16.2 Key Buying Criteria
5.17 Unmet Needs
5.18 Impact of AI on Hla Typing Market
5.18.1 Introduction
5.18.2 Market Potential of Hla Typing Products for Pre Transplant Evaluation
5.18.3 AI Use Cases
5.18.4 Key Companies Implementing AI
5.19 Impact of 2025 US Tariff
5.19.1 Introduction
5.19.2 Key Tariff Rates
5.19.3 Price Impact Analysis
5.19.4 Impact on Country/Region
5.19.4.1 US
5.19.4.2 Europe
5.19.4.3 Asia-Pacific
5.19.5 Impact on End-use Industries

6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Increased Demand for Specialized Consumables to Drive Market
6.3 Instruments
6.3.1 Need for Donor-Recipient Matching and Immunogenetic Research to Aid Growth
6.4 Software & Services
6.4.1 Growing Demand for Advanced and User-Friendly Software to Boost Market

7.1 Introduction
7.2 Molecular Assay Technologies
7.2.1 Pcr-based Molecular Assays
7.2.1.1 Sequence-Specific Primer-Pcr
7.2.1.1.1 Higher Speed, Precision, and Affordability to Favor Growth
7.2.1.2 Sequence-Specific Oligonucleotide-Pcr
7.2.1.2.1 Growing Applications of Pcr in Donor-Recipient Matching, Cancer, Rheumatoid, and Arthritis to Drive Market
7.2.1.3 Real-Time Pcr
7.2.1.3.1 Increasing Preference for Genome-based Molecular Diagnostics to Facilitate Growth
7.2.1.4 Other Pcr-based Molecular Assays
7.2.2 Sequencing-based Molecular Assays
7.2.2.1 Sanger Sequencing
7.2.2.1.1 Increasing Use of Sanger Sequencing in Clinical Settings for Organ and Bone Marrow Transplantations to Aid Growth
7.2.2.2 Next-Generation Sequencing
7.2.2.2.1 Growing Reliance on Outsourcing to Fuel Market
7.2.2.3 Other Sequencing-based Molecular Assays
7.3 Non-Molecular Assay Technologies
7.3.1 Rising Improvements in Healthcare Infrastructure to Augment Growth

8.1 Introduction
8.2 Diagnostic Applications
8.2.1 Donor-Recipient Cross-Matching
8.2.1.1 Increasing Focus on Successful Organ Transplants to Foster Growth
8.2.2 Infectious Disease Testing
8.2.2.1 Rising Prevalence of Infectious Diseases to Accelerate Growth
8.2.3 Cancer Diagnostic & Prevention
8.2.3.1 Increasing Demand for Accurate and Early Cancer Diagnosis to Bolster Growth
8.2.4 Transfusion Therapy
8.2.4.1 Growing Clinical Evidence Supporting Hla Typing to Propel Market
8.2.5 Other Diagnostic Applications
8.3 Research Applications
8.3.1 Expanding Use of Genomic Technologies to Expedite Growth

9.1 Introduction
9.2 Commercial Service Providers
9.2.1 Rising Demand for Outsourced Services to Contribute to Growth
9.3 Hospitals & Transplant Centers
9.3.1 Growing Demand for Organ Transplants to Boost Market
9.4 Research Laboratories & Academic Institutes
9.4.1 Increasing Research Activities to Promote Growth

10.1 Introduction
10.2 North America
10.2.1 Macroeconomic Outlook for North America
10.2.2 US
10.2.2.1 Expanding Donor Registries and Precision Medicine to Propel Market
10.2.3 Canada
10.2.3.1 Evolving Healthcare Landscape to Augment Growth
10.3 Europe
10.3.1 Macroeconomic Outlook for Europe
10.3.2 Germany
10.3.2.1 Growing Investments in Genomic Research and Digital Healthcare to Drive Market
10.3.3 UK
10.3.3.1 Strong Healthcare Infrastructure and Centrally Coordinated Transplant System to Foster Growth
10.3.4 France
10.3.4.1 Growing Adoption for Donor-Recipient Compatibility Testing to Boost Market
10.3.5 Spain
10.3.5.1 Increasing Solid Organ Transplantation Procedures to Facilitate Growth
10.3.6 Italy
10.3.6.1 Supportive Government Policies and Strong Healthcare Infrastructure to Promote Growth
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Macroeconomic Outlook for Asia-Pacific
10.4.2 China
10.4.2.1 Increasing Utilization of Hla Typing for Donor-Recipient Matching to Propel Market
10.4.3 Japan
10.4.3.1 Growing Burden of Chronic Diseases to Boost Market
10.4.4 India
10.4.4.1 Increasing Government Efforts to Offer Free Access to Support Growth
10.4.5 South Korea
10.4.5.1 Advanced Healthcare to Contribute to Growth
10.4.6 Australia
10.4.6.1 Increasing Integration of Genomic Tools in Diagnostics to Promote Growth
10.4.7 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Macroeconomic Outlook for Latin America
10.5.2 Brazil
10.5.2.1 Growing Adoption of Next-Generation Sequencing to Drive Market
10.5.3 Mexico
10.5.3.1 Supportive Business Environment to Bolster Growth
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Macroeconomic Outlook for Middle East & Africa
10.6.2 GCC Countries
10.6.2.1 Improvements in Healthcare Infrastructure to Spur Growth
10.6.3 Rest of Middle East & Africa

11.1 Introduction
11.2 Key Player Strategies
11.2.1 Overview of Strategies Adopted by Key Players in Hla Typing Market
11.3 Revenue Analysis, 2020-2024
11.4 Market Share Analysis, 2024
11.5 Company Valuation and Financial Metrics
11.6 Product/Brand Comparison
11.7 Company Evaluation Matrix: Key Players, 2024
11.7.1 Stars
11.7.2 Emerging Leaders
11.7.3 Pervasive Players
11.7.4 Participants
11.7.5 Company Footprint: Key Players, 2024
11.7.5.1 Company Footprint
11.7.5.2 Region Footprint
11.7.5.3 Product Footprint
11.7.5.4 Technology Footprint
11.7.5.5 Application Footprint
11.7.5.6 End-user Footprint
11.8 Company Evaluation Matrix: Startups/SMEs, 2024
11.8.1 Progressive Companies
11.8.2 Responsive Companies
11.8.3 Dynamic Companies
11.8.4 Starting Blocks
11.8.5 Company Benchmarking: Startups/SMEs, 2024
11.8.5.1 Detailed List of Key Startup/SME Players
11.8.5.2 Competitive Benchmarking of Startups/SMEs
11.9 Competitive Scenario
11.9.1 Product Launches and Approvals
11.9.2 Deals
11.9.3 Expansions

12.1 Major Player
12.1.1 Bd
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Analyst's View
12.1.1.3.1 Key Strengths
12.1.1.3.2 Strategic Choices
12.1.1.3.3 Weaknesses and Competitive Threats
12.1.2 Thermo Fisher Scientific Inc.
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Product Launches and Approvals
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 Analyst's View
12.1.2.4.1 Key Strengths
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses and Competitive Threats
12.1.3 Illumina, Inc.
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Expansions
12.1.3.4 Analyst's View
12.1.3.4.1 Key Strengths
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses and Competitive Threats
12.1.4 Qiagen
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Recent Developments
12.1.4.3.1 Product Launches and Approvals
12.1.4.3.2 Deals
12.1.4.4 Analyst's View
12.1.4.4.1 Key Strengths
12.1.4.4.2 Strategic Choices
12.1.4.4.3 Weaknesses and Competitive Threats
12.1.5 Bio-Rad Laboratories, Inc.
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Product Launches and Approvals
12.1.5.4 Analyst's View
12.1.5.4.1 Key Strengths
12.1.5.4.2 Strategic Choices
12.1.5.4.3 Weaknesses and Competitive Threats
12.1.6 F. Hoffmann-La Roche Ltd.
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.6.3 Recent Developments
12.1.6.3.1 Product Launches and Approvals
12.1.6.3.2 Expansions
12.1.6.4 Analyst's View
12.1.6.4.1 Key Strengths
12.1.6.4.2 Strategic Choices
12.1.6.4.3 Weaknesses and Competitive Threats
12.1.7 Caredx, Inc.
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.7.3 Recent Developments
12.1.7.3.1 Product Launches and Approvals
12.1.7.3.2 Deals
12.1.8 Werfen
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.8.3 Recent Developments
12.1.8.3.1 Product Launches and Approvals
12.1.8.3.2 Deals
12.1.9 Diasorin S.P.A.
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Product Launches and Approvals
12.1.10 Tbg Biotechnology Corporation
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.1.10.3 Recent Developments
12.1.10.3.1 Product Launches and Approvals
12.1.10.3.2 Deals
12.1.11 Fujirebio
12.1.11.1 Business Overview
12.1.11.2 Products Offered
12.1.11.3 Recent Developments
12.1.11.3.1 Deals
12.1.12 Eurobio Scientific
12.1.12.1 Business Overview
12.1.12.2 Products Offered
12.1.12.3 Recent Developments
12.1.12.3.1 Product Launches and Approvals
12.1.12.3.2 Deals
12.1.13 Pacbio
12.1.13.1 Business Overview
12.1.13.2 Products Offered
12.1.13.3 Recent Developments
12.1.13.3.1 Product Launches and Approvals
12.1.13.3.2 Deals
12.1.14 Bag Diagnostics GmbH
12.1.14.1 Business Overview
12.1.14.2 Products Offered
12.1.15 Creative Biolabs
12.1.15.1 Business Overview
12.1.15.2 Products Offered
12.2 Other Players
12.2.1 Histogenetics LLC
12.2.2 Scisco Genetics, Inc.
12.2.3 Inno-Train Diagnostik GmbH
12.2.4 Bionobis
12.2.5 Takara Bio Inc.
12.2.6 Krishgen Biosystems
12.2.7 Sciencell Research Laboratories, Inc.
12.2.8 Proimmune Ltd.
12.2.9 Biofortuna Limited
12.2.10 Alpha Biotech Limited

13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Table 1 Hla Typing Market: Inclusions and Exclusions
Table 2 Hla Typing Market: Risk Analysis
Table 3 Hla Typing Market: Impact Analysis of Market Dynamics
Table 4 Average Selling Price of Key Players, by Instruments, 2024 (USD)
Table 5 Average Selling Price Trend of Instruments, by Region, 2022-2024
Table 6 Hla Typing Market: Role of Companies in Ecosystem
Table 7 Hla Typing Market: Innovations and Patent Registrations, 2024-2025
Table 8 Import Scenario for HS Code 3822, by Country, 2020-2024 (USD Thousand)
Table 9 Export Scenario for HS Code 3822, by Country, 2020-2024 (USD Thousand)
Table 10 Hla Typing Market Key Conferences and Events, 2025-2026
Table 11 Development and Implementation of Information System for Hla Typing Laboratory Management
Table 12 Improved Hla Typing Accuracy Across Diverse Sample Types Using Sequencing-based Assays
Table 13 High-Resolution Extended 6-Loci Hla Typing for Identifying Related Donors in Indian Subcontinent
Table 14 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 16 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Hla Typing Market: Porter's Five Forces Analysis
Table 19 Influence of Stakeholders on Buying Process, by Product & Service (%)
Table 20 Key Buying Criteria for End-users
Table 21 Hla Typing Market: Unmet Needs
Table 22 US Adjusted Reciprocal Tariff Rates
Table 23 Hla Typing Market, by Product & Service, 2023-2030 (USD Million)
Table 24 Hla Typing Market for Reagents & Consumables, by Region, 2023-2030 (USD Million)
Table 25 Hla Typing Market for Instruments, by Region, 2023-2030 (USD Million)
Table 26 Hla Typing Market for Software & Services, by Region, 2023-2030 (USD Million)
Table 27 Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 28 Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 29 Hla Typing Market for Molecular Assay Technologies, by Region, 2023-2030 (USD Million)
Table 30 Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 31 Hla Typing Market for Pcr-based Molecular Assays, by Region, 2023-2030 (USD Million)
Table 32 Hla Typing Market for Sequence-Specific Primer-Pcr Market, by Region, 2023-2030 (USD Million)
Table 33 Hla Typing Market for Sequence-Specific Oligonucleotide-Pcr Market, by Region, 2023-2030 (USD Million)
Table 34 Hla Typing Market for Real-Time Pcr, by Region, 2023-2030 (USD Million)
Table 35 Hla Typing Market for Other Pcr-based Molecular Assays, by Region, 2023-2030 (USD Million)
Table 36 Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 37 Hla Typing Market for Sequencing-based Molecular Assays, by Region, 2023-2030 (USD Million)
Table 38 Hla Typing Market for Sanger Sequencing, by Region, 2023-2030 (USD Million)
Table 39 Hla Typing Market for Next-Generation Sequencing, by Region, 2023-2030 (USD Million)
Table 40 Hla Typing Market for Other Sequencing-based Molecular Assays, by Region, 2023-2030 (USD Million)
Table 41 Hla Typing Market for Non-Molecular Assay Technologies, by Region, 2023-2030 (USD Million)
Table 42 Hla Typing Market, by Application, 2023-2030 (USD Million)
Table 43 Hla Typing Market for Diagnostic Applications, by Type, 2023-2030 (USD Million)
Table 44 Hla Typing Market for Diagnostic Applications, by Region, 2023-2030 (USD Million)
Table 45 Hla Typing Market for Donor-Recipient Cross-Matching, by Region, 2023-2030 (USD Million)
Table 46 Hla Typing Market for Infectious Disease Testing, by Region, 2023-2030 (USD Million)
Table 47 Hla Typing Market for Cancer Diagnosis & Prevention, by Region, 2023-2030 (USD Million)
Table 48 Hla Typing Market for Transfusion Therapy, by Region, 2023-2030 (USD Million)
Table 49 Hla Typing Market for Other Diagnostic Applications, by Region, 2023-2030 (USD Million)
Table 50 Hla Typing Market for Research Applications, by Region, 2023-2030 (USD Million)
Table 51 Hla Typing Market, by End-user, 2023-2030 (USD Million)
Table 52 Hla Typing Market for Commercial Service Providers, by Region, 2023-2030 (USD Million)
Table 53 Hla Typing Market for Hospitals & Transplant Centers, by Region, 2023-2030 (USD Million)
Table 54 Hla Typing Market for Research Laboratories & Academic Institutes, by Region, 2023-2030 (USD Million)
Table 55 Hla Typing for Transplant Market: Transplant Volume by Type, 2023 (Number of Transplants)
Table 56 North America: Transplant Volume, 2024
Table 57 North America: Hla Typing Market, by Country, 2023-2030 (USD Million)
Table 58 North America: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 59 North America: Hla Typing Market, by Product & Service, 2023-2030 (USD Million)
Table 60 North America: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 61 North America: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 62 North America: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 63 North America: Hla Typing Market, by Application, 2023-2030 (USD Million)
Table 64 North America: Hla Typing Market for Diagnostic Applications, by Type, 2023-2030 (USD Million)
Table 65 North America: Hla Typing Market, by End-user, 2023-2030 (USD Million)
Table 66 US: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 67 US: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 68 US: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 69 US: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 70 Canada: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 71 Canada: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 72 Canada: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 73 Canada: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 74 Europe: Transplant Volume, 2024
Table 75 Europe: Hla Typing Market, by Country, 2023-2030 (USD Million)
Table 76 Europe: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 77 Europe: Hla Typing Market, by Product & Service, 2023-2030 (USD Million)
Table 78 Europe: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 79 Europe: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 80 Europe: Hla Typing Market for Pcr-based Molecular Assays Technologies, by Type, 2023-2030 (USD Million)
Table 81 Europe: Hla Typing Market, by Application, 2023-2030 (USD Million)
Table 82 Europe: Hla Typing Market for Diagnostic Applications, by Type, 2023-2030 (USD Million)
Table 83 Europe: Hla Typing Market, by End-user, 2023-2030 (USD Million)
Table 84 Germany: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 85 Germany: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 86 Germany: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 87 Germany: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 88 UK: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 89 UK: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 90 UK: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 91 UK: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 92 France: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 93 France: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 94 France: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 95 France: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 96 Spain: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 97 Spain: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 98 Spain: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 99 Spain: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 100 Italy: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 101 Italy: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 102 Italy: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 103 Italy: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 104 Rest of Europe: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 105 Rest of Europe: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 106 Rest of Europe: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 107 Rest of Europe: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 108 Asia-Pacific: Transplant Volume, 2024
Table 109 Asia-Pacific: Hla Typing Market, by Country, 2023-2030 (USD Million)
Table 110 Asia-Pacific: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 111 Asia-Pacific: Hla Typing Market, by Product & Service, 2023-2030 (USD Million)
Table 112 Asia-Pacific: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 113 Asia-Pacific: Hla Typing Market for Pcr-based Assay Technologies, by Type, 2023-2030 (USD Million)
Table 114 Asia-Pacific: Hla Typing Market for Pcr-based Molecular Assays Technologies, by Type, 2023-2030 (USD Million)
Table 115 Asia-Pacific: Hla Typing Market, by Application, 2023-2030 (USD Million)
Table 116 Asia-Pacific: Hla Typing Market for Diagnostic Applications, by Type, 2023-2030 (USD Million)
Table 117 Asia-Pacific: Hla Typing Market, by End-user, 2023-2030 (USD Million)
Table 118 China: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 119 China: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 120 China: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 121 China: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 122 Japan: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 123 Japan: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 124 Japan: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 125 Japan: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 126 India: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 127 India: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 128 India: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 129 India: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 130 South Korea: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 131 South Korea: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 132 South Korea: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 133 South Korea: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 134 Australia: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 135 Australia: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 136 Australia: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 137 Australia: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 138 Rest of Asia-Pacific: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 139 Rest of Asia-Pacific: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 140 Rest of Asia-Pacific: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 141 Rest of Asia-Pacific: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 142 Latin America: Transplant Volume, 2024
Table 143 Latin America: Hla Typing Market, by Country, 2023-2030 (USD Million)
Table 144 Latin America: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 145 Latin America: Hla Typing Market, by Product & Service, 2023-2030 (USD Million)
Table 146 Latin America: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 147 Latin America: Hla Typing Market for Pcr-based Molecular Assays Technologies, by Type, 2023-2030 (USD Million)
Table 148 Latin America: Hla Typing Market for Pcr-based Assay Technologies, by Type, 2023-2030 (USD Million)
Table 149 Latin America: Hla Typing Market, by Application, 2023-2030 (USD Million)
Table 150 Latin America: Hla Typing Market, by Diagnostic Application, 2023-2030 (USD Million)
Table 151 Latin America: Hla Typing Market, by End-user, 2023-2030 (USD Million)
Table 152 Brazil: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 153 Brazil: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 154 Brazil: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 155 Brazil: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 156 Mexico: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 157 Mexico: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 158 Mexico: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 159 Mexico: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 160 Rest of Latin America: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 161 Rest of Latin America: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 162 Rest of Latin America: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 163 Rest of Latin America: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 164 Middle East & Africa: Transplant Volume, 2024
Table 165 Middle East & Africa: Hla Typing Market, by Region, 2023-2030 (USD Million)
Table 166 Middle East & Africa: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 167 Middle East & Africa: Hla Typing Market, by Product & Service, 2023-2030 (USD Million)
Table 168 Middle East & Africa: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 169 Middle East & Africa: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 170 Middle East & Africa: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 171 Middle East & Africa: Hla Typing Market, by Application, 2023-2030 (USD Million)
Table 172 Middle East & Africa: Hla Typing Market, by Diagnostic Application, 2023-2030 (USD Million)
Table 173 Middle East & Africa: Hla Typing Market, by End-user, 2023-2030 (USD Million)
Table 174 GCC Countries: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 175 GCC Countries: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 176 GCC Countries: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 177 GCC Countries: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 178 Rest of Middle East & Africa: Hla Typing Market, by Technology, 2023-2030 (USD Million)
Table 179 Rest of Middle East & Africa: Hla Typing Market for Molecular Assay Technologies, by Type, 2023-2030 (USD Million)
Table 180 Rest of Middle East & Africa: Hla Typing Market for Pcr-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 181 Rest of Middle East & Africa: Hla Typing Market for Sequencing-based Molecular Assays, by Type, 2023-2030 (USD Million)
Table 182 Overview of Strategies Deployed by Key Companies in Hla Typing Market
Table 183 Hla Typing Market: Degree of Competition
Table 184 Hla Typing Market: Region Footprint
Table 185 Hla Typing Market: Product & Service Footprint
Table 186 Hla Typing Market: Technology Footprint
Table 187 Hla Typing Market: Application Footprint
Table 188 Hla Typing Market: End-user Footprint
Table 189 Hla Typing Market: Detailed List of Key Startup/SME Players
Table 190 Hla Typing Market: Competitive Benchmarking of Startups/SMEs
Table 191 Hla Typing Market: Product Launches and Approvals, January 2021-April 2025
Table 192 Hla Typing Market: Deals, January 2021-April 2025
Table 193 Hla Typing Market: Expansions, January 2021-April 2025
Table 194 Bd: Company Overview
Table 195 Bd: Products Offered
Table 196 Thermo Fisher Scientific, Inc.: Company Overview
Table 197 Thermo Fisher Scientific Inc.: Products Offered
Table 198 Thermo Fisher Scientific, Inc.: Product Launches and Approvals, January 2022-April 2025
Table 199 Thermo Fisher Scientific Inc.: Deals, January 2021-April 2025
Table 200 Thermo Fisher Scientific Inc.: Expansions, January 2021-April 2025
Table 201 Illumina, Inc.: Company Overview
Table 202 Illumina, Inc.: Products Offered
Table 203 Illumina, Inc.: Expansions, January 2021-April 2025
Table 204 Qiagen: Company Overview
Table 205 Qiagen: Products Offered
Table 206 Qiagen: Product Launches and Approvals, January 2022-April 2025
Table 207 Qiagen: Deals, January 2021-April 2025
Table 208 Bio-Rad Laboratories, Inc.: Company Overview
Table 209 Bio-Rad Laboratories, Inc.: Products Offered
Table 210 Bio-Rad Laboratories, Inc.: Product Launches and Approvals, January 2022-April 2025
Table 211 F. Hoffmann-La Roche Ltd.: Company Overview
Table 212 F. Hoffmann-La Roche Ltd.: Products Offered
Table 213 F. Hoffmann-La Roche Ltd.: Product Launches and Approvals, January 2022-April 2025
Table 214 F. Hoffmann-La Roche Ltd.: Expansions, January 2021-April 2025
Table 215 Caredx, Inc.: Company Overview
Table 216 Caredx, Inc.: Products Offered
Table 217 Caredx, Inc.: Product Launches and Approvals, January 2022-April 2025
Table 218 Caredx, Inc.: Deals, January 2022-April 2025
Table 219 Werfen: Company Overview
Table 220 Werfen: Products Offered
Table 221 Werfen: Product Launches and Approvals, January 2022-April 2025
Table 222 Werfen: Deals, January 2022-April 2025
Table 223 Diasorin S.P.A.: Company Overview
Table 224 Diasorin S.P.A.: Products Offered
Table 225 Diasorin S.P.A.: Product Launches and Approvals, January 2022-April 2025
Table 226 Tbg Biotechnology Corporation: Company Overview
Table 227 Tbg Biotechnology Corporation: Products Offered
Table 228 Tbg Biotechnology Corporation: Product Launches and Approvals, January 2022-April 2025
Table 229 Tbg Biotechnology Corporation: Deals, January 2022-April 2025
Table 230 Fujirebio: Company Overview
Table 231 Fujirebio: Products Offered
Table 232 Fujirebio: Deals, January 2022-April 2025
Table 233 Eurobio Scientific.: Company Overview
Table 234 Eurobio Scientific: Products Offered
Table 235 Eurobio Scientific: Product Launches and Approvals, January 2022-April 2025
Table 236 Eurobio Scientific: Deals, January 2022-April 2025
Table 237 Pacbio: Company Overview
Table 238 Pacbio: Products Offered
Table 239 Pacbio: Product Launches and Approvals, January 2022-April 2025
Table 240 Pacbio: Deals, January 2022-April 2025
Table 241 Bag Diagnostics GmbH: Company Overview
Table 242 Bag Diagnostics GmbH: Products Offered
Table 243 Creative Biolabs: Company Overview
Table 244 Creative Biolabs: Products Offered
Table 245 Histogenetics LLC: Company Overview
Table 246 Scisco Genetics, Inc.: Company Overview
Table 247 Inno-Train Diagnostik GmbH: Company Overview
Table 248 Bionobis: Company Overview
Table 249 Takara Bio Inc.: Company Overview
Table 250 Krishgen Biosystems: Company Overview
Table 251 Sciencell Research Laboratories, Inc.: Company Overview
Table 252 Proimmune Ltd.: Company Overview
Table 253 Biofortuna Limited: Company Overview
Table 254 Alpha Biotech Limited: Company Overview

Figure 1 Hla Typing Market Segmentation and Regional Scope
Figure 2 Hla Typing Market: Years Considered
Figure 3 Hla Typing Market: Research Design
Figure 4 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 5 Research Methodology: Hypothesis Building
Figure 6 Market Size Estimation: Revenue Share Analysis, 2024
Figure 7 Hla Typing Market: Market Size Estimation Methodology
Figure 8 Hla Typing Market: Growth Projections Based on Revenue Impact of Key Macro Indicators
Figure 9 Data Triangulation
Figure 10 Research Limitations
Figure 11 Hla Typing Market, by Technology, 2025 vs. 2030 (USD Million)
Figure 12 Hla Typing Market, by Product &Services, 2025 vs. 2030 (USD Million)
Figure 13 Hla Typing Market, by Application, 2025 vs. 2030 (USD Million)
Figure 14 Hla Typing Market, by End-user, 2025 vs. 2030 (USD Million)
Figure 15 Geographic Snapshot of Hla Typing Market
Figure 16 Growing Number of Organ Transplant Procedures to Drive Market
Figure 17 China to Register Highest CAGR During Forecast Period
Figure 18 Hla Typing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Trends/Disruptions Impacting Customer Business
Figure 20 Average Selling Price of Instruments, 2024 (USD Thousand)
Figure 21 Average Selling Price of Reagents, 2024 (USD Thousand)
Figure 22 Average Selling Price of Instruments, by Region, 2024 (USD Thousand)
Figure 23 Hla Typing Market: Value Chain Analysis
Figure 24 Hla Typing Market: Supply Chain Analysis
Figure 25 Hla Typing Market: Ecosystem Analysis
Figure 26 Investments and Funding Scenario, 2019-2023
Figure 27 Number of Deals in Market, by Key Player, 2019-2023
Figure 28 Value of Deals in Market, by Key Player, 2019-2023 (USD)
Figure 29 Hla Typing Market: Patent Analysis, January 2014-December 2024
Figure 30 Hla Typing Market: Import Scenario for HS Code 3822, 2020-2024
Figure 31 Hla Typing Market: Export Scenario for HS Code 3822, 2020-2024
Figure 32 Hla Typing Market: Porter's Five Forces Analysis
Figure 33 Influence of Stakeholders on Buying Process, by Product & Service
Figure 34 Key Buying Criteria for End-users
Figure 35 North America: Hla Typing Market Snapshot
Figure 36 Asia: Hla Typing Market Snapshot
Figure 37 Revenue Analysis of Key Players in Hla Typing Market, 2020-2024
Figure 38 Hla Typing Market Share Analysis, 2024
Figure 39 EV/EBITDA of Key Vendors
Figure 40 5-Year Stock Beta of Key Vendors
Figure 41 Hla Typing Market: Product/Brand Comparison
Figure 42 Hla Typing Market: Company Evaluation Matrix (Key Players), 2024
Figure 43 Hla Typing Market: Company Footprint
Figure 44 Hla Typing Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 45 Bd: Company Snapshot (2024)
Figure 46 Thermo Fisher Scientific Inc.: Company Snapshot (2024)
Figure 47 Illumina, Inc.: Company Snapshot (2024)
Figure 48 Qiagen: Company Snapshot (2024)
Figure 49 Bio-Rad Laboratories, Inc.: Company Snapshot (2024)
Figure 50 F. Hoffmann-La Roche Ltd.: Company Snapshot (2024)
Figure 51 Caredx, Inc.: Company Snapshot (2024)
Figure 52 Diasorin S.P.A.: Company Snapshot (2024)
Figure 53 Eurobio Scientific: Company Snapshot (2024)
Figure 54 Pacbio: Company Snapshot (2022)